Adial Pharmaceuticals Inc (ADIL) Quote

Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

Looks like green very soon !

Interesting !

ADIL............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Source: GlobeNewswire Inc.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the progression to the second cohort in the pharmacokinetics study of AD04, the Company’s lead investigational genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients (defined as < 10 drinks/drinking day), following the successful completion of the first cohort. Topline results from both cohorts are expected to be announced during the fourth quarter of 2024.
Cary Claiborne, President and Chief Executive Officer of Adial commented, “We are pleased with the progress of our pharmacokinetics study of AD04. The successful completion of the first cohort allows us to advance to the second cohort as planned, staying on track with our projected timeline. The results from both cohorts will offer invaluable insights that are critical for the design of our upcoming Phase 3 Clinical Trial. We anticipate engaging with the FDA following receipt of the topline data from this study and seek their feedback on the overall design of our Phase 3 program.”

The pharmacokinetics study was initiated in June 2024 and is expected to be completed during the fourth quarter of 2024. The single-center open-label relative bioavailability and dose proportionality study will enroll up to 30 healthy adult volunteers and compare the pharmacokinetic profile of AD04 when administered as an oral dose of 0.33 mg with or without food against a reference standard product. This study will provide valuable information on the pharmacokinetic properties of AD04.

ADIL under $2

ADIL under $2

ADIL....................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

ADIL under $1

What leaked?

Where to now ADIL?

Sorry to say, I was deadly wrong on this one... But I´m holding and adding.

Holding up very well. And flagging for the next uptick. Jep, it‘s supposed to happen…

Isn’t this stock suppose to be ticking up

ADIL: Boy, am I eatin' 'CROW' on this one, or what!!! (Likely Close today at $5.00, just to humiliate me even more!!!)


"Heck, I trash a stock, & then it soars to the MOON!!! I HATE when this happens!!! NO RESPECT, at all!!!"

ADIL...............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

ADIL: This is what one gets behind 'investing' in a mere Ultra-Pre-Human-Trials, Petri Dish, Test Tude, Theoretical Journal Paper, and otherwise, 'THE-GREAT-ALCOHOL-ADDICTION-MAYBE-COULD-BE-MIGHT-BE-YEARS-FROM-NOW-CURE-OF-THE-WEEK', fluffy, Wall Street 'news' routine.

tHANKS adiL 1.82

Congrats- chart looks primed for more…

filled 1.97 on that dip

$ADIL 2.54 LET MORE GO, WHAT A GREAT STOCK TO TRADE

https://finviz.com/quote.ashx?t=ADIL&ty=c&ta=1&p=d

$adil lots of trade oppshttps://t.co/0eN6zQg6CR— THE FINAL COUNTDOWN (@READY_2_PROFIT) April 10, 2024

CONGRAT$

nhod https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174209695

Overdue- go time again!

What leaked?

Added more shares - rumors about a big pharma deal hopefully get published soon…

ADIL 10Q due 3/18

I'm totally out. It was a nice bounce. We will see if it drops back into a buy zone. GL all.

Except for the failed Phase III and then the company not doing anything except for a reverse split in two years.

They need to run more trials it will take 3 to 4 years to prove effectiveness and a higher probability it will fail those trials.

Having a patent on something that doesn't work is not worth much.

Jmho

ADIL................................................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783

“AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity” my projected selling price just went higher! I didn’t know it treated gambling and obesity in addition to alcoholism and opioid addiction! BOOM!!!

BOOM! Posted yesterday! “ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that!”

I'm now looking for a nice bounce over $5

This one looks good

$ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that! 🚀

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

I'm looking for a nice bounce back over $1

ADIL new 52 week low

My stop loss hit at 1.04

ADIL new 52 week low

ADIL new 52 week low

Looks like a nice entry point here.

Cat got your tongue?

ADIL new 52 week low

ADIL new 52=week low

ADIL new 52 week low

ADIL new 52 week high

ADIL new 52 week low

$ADIL another small bio getting attention now pic.twitter.com/oCNyRr81Tj— STOCKS Gambino (@StocksGambino) December 29, 2023

Volume picking up but also dropping in price. Looks like there is historic support in the 1.80 area.